Welcome to LookChem.com Sign In|Join Free
  • or
5H-Thieno[2,3-c]pyran-5-one, 4,7-dihydro-3-[4-(methylsulfonyl)phenyl]-2-phenyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

178614-32-9

Post Buying Request

178614-32-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

178614-32-9 Usage

General Description

5H-Thieno[2,3-c]pyran-5-one, 4,7-dihydro-3-[4-(methylsulfonyl)phenyl]-2-phenyl- is a chemical compound that belongs to the class of thienopyranones. It is a heterocyclic organic compound that contains a thieno[2,3-c]pyran-5-one core structure, with a dihydrophenyl and a methylsulfonylphenyl substituent. 5H-Thieno[2,3-c]pyran-5-one, 4,7-dihydro-3-[4-(methylsulfonyl)phenyl]-2-phenyl- has potential pharmacological properties and can be used in medicinal research for the development of new drugs. Its chemical structure suggests that it may have biological activities and it could be used as a starting point for the synthesis of new compounds with improved pharmacological properties.

Check Digit Verification of cas no

The CAS Registry Mumber 178614-32-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,6,1 and 4 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 178614-32:
(8*1)+(7*7)+(6*8)+(5*6)+(4*1)+(3*4)+(2*3)+(1*2)=159
159 % 10 = 9
So 178614-32-9 is a valid CAS Registry Number.

178614-32-9Downstream Products

178614-32-9Relevant academic research and scientific papers

Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2

-

, (2008/06/13)

The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. STR1 The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 178614-32-9